Michael C. Dugan's most recent trade in Biocept Inc was a trade of 150,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 31, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Biocept Inc | Michael C. Dugan | Chief Med Off & Med. Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
Biocept Inc | Michael C. Dugan | Chief Med Off & Med. Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 69,000 | 69,000 | - | - | Employee Stock Option (right to buy) | |
Biocept Inc | Michael C. Dugan | Chief Med Off & Med. Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2020 | 54,900 | 54,900 | - | - | Employee Stock Option (right to buy) |